IL17A and periodontitis: Altogether, these findings highlight the IL-23/IL-17 (or IL-23) axis as an intriguing immunopathogenic mechanism that warrants further investigation as a possible therapeutic target in LAD-I and other related disorders, like generalized aggressive periodontitis associated [25].